XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
Components of Provision for Income Taxes

Significant components of the tax expense (benefit) recognized in the accompanying consolidated statements of operations for the Three Months ended March 31, 2022 and March 31, 2021 are as follows:

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

 

 

March 31, 2022

 

 

March 31, 2021

 

 

 

Current tax benefit

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(361,715

)

 

$

911,648

 

 

 

State

 

 

(48,102

)

 

 

188,624

 

 

 

Total current tax  expense (benefit)

 

 

(409,817

)

 

 

1,100,272

 

 

 

Deferred tax expense

 

 

(1,021,132

)

 

 

8,214

 

 

 

Valuation allowance (expense)

 

 

1,430,949

 

 

 

(1,105,002

)

 

 

Income tax (reduction) benefit

 

$

-

 

 

$

3,484

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of Reconciliation of Tax Provision with Expected Provision

The reconciliation of the income tax computed at the combined federal and state statutory rate of 23.8% for the Three Months ended March 31, 2022 and 24.3% for the Three Months ended March 31, 2021 to the income tax benefit is as follows:

 

 

 

Three Months Ended

 

Three Months Ended

 

 

 

 

March 31, 2022

 

March 31, 2021

 

 

Benefit on net loss

 

$

(1,432,139

)

23.8%

 

$

1,107,447

 

24.3%

 

 

Nondeductible expenses

 

 

1,190

 

0.0%

 

 

1,039

 

0.0%

 

 

Valuation allowance (expense)

 

 

1,430,949

 

(23.8)%

 

 

(1,105,002

)

(24.3)%

 

 

Tax benefit/effective rate

 

$

-

 

(—)%

 

$

3,484

 

(—)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Components of Deferred Tax Assets and Liabilities

The significant components of the Company’s deferred tax liabilities and assets as of March 31, 2022 and December 31, 2021 are as follows: 

 

 

 

As of March 31, 2022

 

 

As of December 31, 2021

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Deferred vendor stock compensation

 

$

(182,926

)

 

$

(261,323

)

Total deferred tax liabilities

 

 

(182,926

)

 

 

(261,323

)

Deferred tax assets:

 

 

 

 

 

 

 

 

Loss carryforwards

 

 

2,511,217

 

 

 

2,101,401

 

Step up in basis at contribution to C-Corp

 

 

449,165

 

 

 

461,078

 

Stock option expense

 

 

1,459,575

 

 

 

669,959

 

Step up in basis - purchase of non-controlling interest

 

 

41,439

 

 

 

42,529

 

Allowance for credit losses

 

 

16,539

 

 

 

16,539

 

Unrealized loss on securities

 

 

382,407

 

 

 

216,284

 

Total deferred tax asset

 

 

4,860,342

 

 

 

3,507,790

 

Valuation allowance

 

 

(4,677,416

)

 

 

(3,246,467

)

Net deferred tax asset (liability)

 

$

-

 

 

$

-